Comments
Loading...
OrthoPediatrics Stock Guidance | NASDAQ:KIDS | Benzinga
OrthoPediatrics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/04/2025 | KIDS | OrthoPediatrics | FY | 2025 | — | — | — | $235.00M | $242.00M | $240.78M | Get Alert |
| 01/13/2025 | KIDS | OrthoPediatrics | FY | 2024 | — | — | — | $204.70M | $204.70M | $202.78M | Get Alert |
| 01/13/2025 | KIDS | OrthoPediatrics | FY | 2025 | — | — | — | $235.00M | $242.00M | $239.95M | Get Alert |
| 01/13/2025 | KIDS | OrthoPediatrics | Q4 | 2024 | — | — | — | $52.70M | $52.70M | $50.73M | Get Alert |
| 11/06/2024 | KIDS | OrthoPediatrics | FY | 2024 | — | — | — | $202.00M | $204.00M | $201.56M | Get Alert |
| 08/05/2024 | KIDS | OrthoPediatrics | FY | 2024 | — | — | — | $200.00M | $203.00M | $201.55M | Get Alert |
| 05/06/2024 | KIDS | OrthoPediatrics | FY | 2024 | — | — | — | $200.00M | $203.00M | $198.12M | Get Alert |
| 03/06/2024 | KIDS | OrthoPediatrics | FY | 2024 | — | — | — | $197.00M | $200.00M | $182.90M | Get Alert |
| 01/08/2024 | KIDS | OrthoPediatrics | FY | 2023 | — | — | — | $148.70M | $148.70M | $148.88M | Get Alert |
| 01/08/2024 | KIDS | OrthoPediatrics | Q4 | 2023 | — | — | — | $37.60M | $37.60M | $37.77M | Get Alert |
| 01/08/2024 | KIDS | OrthoPediatrics | FY | 2024 | — | — | — | $197.00M | $200.00M | $177.70M | Get Alert |
| 11/06/2023 | KIDS | OrthoPediatrics | FY | 2023 | — | — | — | $148.00M | $151.00M | $149.17M | Get Alert |
| 07/31/2023 | KIDS | OrthoPediatrics | FY | 2023 | — | — | — | $148.00M | $151.00M | $149.28M | Get Alert |
| 05/01/2023 | KIDS | OrthoPediatrics | FY | 2023 | — | — | — | $148.00M | $151.00M | $147.32M | Get Alert |
| 02/28/2023 | KIDS | OrthoPediatrics | FY | 2023 | — | — | — | $146.00M | $149.00M | $149.57M | Get Alert |
| 01/09/2023 | KIDS | OrthoPediatrics | FY | 2023 | — | — | — | $146.00M | $149.00M | $151.82M | Get Alert |
| 01/09/2023 | KIDS | OrthoPediatrics | FY | 2022 | — | — | — | $122.30M | $122.30M | $124.48M | Get Alert |
| 01/09/2023 | KIDS | OrthoPediatrics | Q4 | 2022 | — | — | — | $31.00M | $31.00M | $33.18M | Get Alert |
| 10/31/2022 | KIDS | OrthoPediatrics | FY | 2022 | — | — | — | $124.00M | $125.00M | $128.35M | Get Alert |
| 08/03/2022 | KIDS | OrthoPediatrics | FY | 2022 | — | — | — | $127.00M | $130.00M | $124.45M | Get Alert |
| 07/05/2022 | KIDS | OrthoPediatrics | FY | 2022 | — | — | — | $125.00M | $128.00M | $123.58M | Get Alert |
| 06/14/2022 | KIDS | OrthoPediatrics | FY | 2022 | — | — | — | $125.00M | $128.00M | $123.15M | Get Alert |
| 05/04/2022 | KIDS | OrthoPediatrics | FY | 2022 | — | — | — | $122.00M | $125.00M | $118.82M | Get Alert |
| 03/02/2022 | KIDS | OrthoPediatrics | FY | 2022 | — | — | — | $118.00M | $121.00M | $119.19M | Get Alert |
| 01/10/2022 | KIDS | OrthoPediatrics | FY | 2021 | — | — | — | $98.00M | $98.00M | $97.93M | Get Alert |
| 01/10/2022 | KIDS | OrthoPediatrics | Q4 | 2021 | — | — | — | $24.80M | $24.80M | $24.71M | Get Alert |
| 11/03/2021 | KIDS | OrthoPediatrics | FY | 2021 | — | — | — | $97.00M | $101.00M | $98.60M | Get Alert |
| 10/13/2021 | KIDS | OrthoPediatrics | Q3 | 2021 | — | — | — | $25.10M | $25.10M | $26.48M | Get Alert |
| 10/13/2021 | KIDS | OrthoPediatrics | FY | 2021 | — | — | — | $97.00M | $101.00M | $98.74M | Get Alert |
| 08/04/2021 | KIDS | OrthoPediatrics | FY | 2021 | — | — | — | $97.00M | $101.00M | $96.09M | Get Alert |
| 05/05/2021 | KIDS | OrthoPediatrics | FY | 2021 | — | — | — | $94.00M | $98.00M | $95.00M | Get Alert |
| 03/10/2021 | KIDS | OrthoPediatrics | FY | 2021 | — | — | — | $93.00M | $98.00M | $97.62M | Get Alert |
| 01/11/2021 | KIDS | OrthoPediatrics | FY | 2020 | — | — | — | $73.80M | $73.80M | $72.46M | Get Alert |
| 01/11/2021 | KIDS | OrthoPediatrics | Q4 | 2020 | — | — | — | $21.70M | $21.70M | $20.31M | Get Alert |
FAQ
What is the most recent guidance for OrthoPediatrics (KIDS)?
There have been no specific sales or earnings guidance reported for OrthoPediatrics in recent months.
Browse guidance and forecast on all stocks.